Skip to main content

People in the News: An Interim CEO at Vermillion and More

Premium

Vermillion has named Bruce Huebner interim CEO, taking over for Gail Page, who will serve as a strategic advisor to the company. The company’s board has formed a succession committee and retained an executive search firm to find a new CEO to fill the post long-term.

Huebner will continue to serve on the company’s board of directors. His executive management experience includes stints as president of Osmetech, president and CEO of Nanogen, and executive vice president and chief operating officer at Gen-Probe.


CombiMatrix has appointed Jeremy Jones to its board of directors.

Jones is currently chairman of healthcare staffing firm On Assignment as well as a member of the advisory board of MedidaMetrics. Previously he served as chairman of the Health Industry Distributors Association and on the board of the National Association of Medical Equipment Services.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.